A-211 - Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan
| Autor: | Namikawa, K., Mori, S., Kiniwa, Y., Takenouchi, T., Nakamura, M., Oashi, K., Yoshikawa, S., Muto, Y., Uchi, H., Yoshino, K., Maekawa, T., Ohe, S., Uhara, H., Ichigozaki, Y., Asai, J., Nakamura, Y., Ishizuki, S., Matsuzawa, T., Kitagawa, H., Nomura, M., Funakoshi, T., Matsushita, S., Maeda, T., Hatta, N., Tsutsui, K., Nakagawa, T., Hoashi, T., Ishikawa, H., Nakama, K., Ito, T., Miyagawa, T., Nishizawa, A., Yanagi, T., Kato, Y., Fujiwara, S., Yamamoto, Y., Iwata, H., Ogata, D., Fujisawa, Y. |
|---|---|
| Zdroj: | In EJC Skin Cancer 2024 2 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|